Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNYNF crawled date : 2021 - 10 - 27 save search
BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
Published: 2021-10-27 (Crawled : 20:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 2.48%
H: 6.83%
C: 6.39%
financial results results
Sanofi: Information concerning the total number of voting rights and shares - September 2021
Published: 2021-10-27 (Crawled : 19:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
Patients with Non-Small-Cell Lung Cancer with Brain Metastases: New Data on the Significant Challenges for which Physicians Feel Unequipped
Published: 2021-10-27 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
lung cancer cancer train brain metastases
Deciduous Therapeutics Announces Appointments to the Board, SAB, and Advisor Roles
Published: 2021-10-27 (Crawled : 15:15) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
Published: 2021-10-27 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
financial results results
Kymera Therapeutics Presents Positive Data Demonstrating Robust IRAK4 Degradation and First Proof-of-Biology with Inhibition of Cytokine Induction from the Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers
Published: 2021-10-27 (Crawled : 13:15) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: -0.5%
H: 3.25%
C: 0.66%
phase 1 positive trial
Cytovation announces the appointment of Bo Jesper Hansen as Strategic Advisor
Published: 2021-10-27 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
Sodexo Fiscal 2021 Results: Solid pick-up in activity and better than expected performance
Published: 2021-10-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.